SEC Form 4 · accession 0001225208-15-008367
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Pierce
Officer — SVP and President, Endoscopy
Period of report
Mar 20, 2015
Accepted (ET)
Mar 23, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2015 | M | 9,550 | $16.02 | A | 35,150 | D | |
| Common Stock | Mar 20, 2015 | M | 8,500 | $8.30 | A | 43,650 | D | |
| Common Stock | Mar 20, 2015 | S | 18,050 | $18.00 | D | 25,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $8.30 | Mar 20, 2015 | M | 8,500 | D | — | Feb 24, 2019 | Common Stock | 8,500 | 16,512 | D |
| Stock Option (Right to Buy)F3 | $16.02 | Mar 20, 2015 | M | 9,550 | D | — | Jul 24, 2016 | Common Stock | 9,550 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.
- F3Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on July 24, 2007, the first anniversary of the date of grant.